Stocks and Investing Stocks and Investing
Mon, June 6, 2016
Sun, June 5, 2016
Fri, June 3, 2016
Thu, June 2, 2016
Wed, June 1, 2016
Tue, May 31, 2016
Fri, May 27, 2016
Thu, May 26, 2016
Wed, May 25, 2016
Tue, May 24, 2016
Mon, May 23, 2016
Fri, May 20, 2016
Thu, May 19, 2016
Wed, May 18, 2016
Tue, May 17, 2016
Mon, May 16, 2016
Fri, May 13, 2016
Thu, May 12, 2016
Wed, May 11, 2016
Tue, May 10, 2016
Mon, May 9, 2016
Fri, May 6, 2016
Thu, May 5, 2016
Wed, May 4, 2016

Vamil Divan Initiated (TEVA) at Hold and Held Target at $60 on, May 4th, 2016


Published on 2024-10-25 12:33:21 - WOPRAI, Vamil Divan
  Print publication without navigation


Vamil Divan of Credit Suisse, Initiated "Teva Pharmaceutical Industries Limited" (TEVA) at Hold and Held Target at $60 on, May 4th, 2016.

Vamil has made no other calls on TEVA in the last 4 months.



There are 3 other peers that have a rating on TEVA. Out of the 3 peers that are also analyzing TEVA, 0 agree with Vamil's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Vamil


  • David Risinger of "Morgan Stanley" Maintained at Buy with Decreased Target to $69 on, Tuesday, May 3rd, 2016
  • Jacob Hughes of "Wells Fargo" Initiated at Buy on, Friday, February 19th, 2016
  • Gregg Gilbert of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $80 on, Friday, February 12th, 2016